Estrogen receptor immunocytochemistry in endometrial carcinoma: A prognostic marker for survival

Gynecologic Oncology

Volumn 63, Issue 1, 1996, Pages 28-33

  Pertschuk, Louis P ^a,e   Masood, Shahla ^b   Simone, Jennifer ^c   Feldman, Joseph G ^a   Fruchter, Rachel G ^a   Axiotis, Constantine A ^a   Greene, Geoffrey L ^d  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^c Oschner Clinic Foundation   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e Box 25 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PEROXIDASE ANTIPEROXIDASE COMPLEX; PRIORITY JOURNAL;

EID: 0030271951     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0273     Document Type: Article

References (31)

1. Mortel, R., Zaino, R., and Satyaswaroop, P. G. Heterogeneity and progesterone receptor distribution in endometrial adenocarcinoma, Cancer 57, 113-116 (1984).
2. Pertschuk, L. P., Beddoe, A. M., Gorelic, L. S., and Shain, S. A. Immunocytochemical assay of estrogen receptors in endometrial carcinoma with monoclonal antibodies, Cancer 57, 1000-1004 (1986).
3. Brustein, S., Fruchter, R., Greene, G. L., and Pertschuk, L. P. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: A preliminary evaluation, Mod. Pathol. 2, 449-455 (1989).
4. Satyaswaroop, P. G., and Mortel, R. Sex steroid receptors in endometrial carcinoma, Gynecol. Oncol. 50, 278-280 (1993).
5. Pertschuk, L. P., Kim, D. S., Nayer, K., Feldman, J. G., Eisenberg, K. B., Carter, A. C., Rong, Z. T., Thelmo, W. T., Fleisher, J., and Greene, G. L. Immunocytochemical estrogen and progesterone receptor assays in breast cancer with monoclonal antibodies: Histopathologic, demographic and biochemical correlations and relationship to endocrine response and survival, Cancer 66, 1663-1670 (1990).
6. Greene, G. L., Fitch, F. W., and Jensen, E. V. Monoclonal antibodies to estrophilin: Probes for the study of estrogen receptors, Proc. Natl. Acad. Sci. USA 77, 157-161 (1980).
7. Greene, G. L., and Jensen, E. V. Monoclonal antibodies as probes for estrogen receptor detection and characterization, J. Steroid Biochem. 16, 353-359 (1982).
8. Press, M. F., and Greene, G. L. Localization of progesterone receptor in breast cancer with monoclonal antibodies to the human progesterone receptor, Endocrinol. 122, 1165-1175 (1988).
9. Mehta, C. R., and Patel, N. R. Exact tests 6.1 for windows. SPSS, Inc., Chicago 1995.
10. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995, CA Cancer J. Clin. 45, 8-30 (1995).
11. Creasman, W. T., and DiSaia, P. J. Clinical gynecological oncology, Mosby Year Book, St Louis, MO, pp. 156-189 (1993).
12. Creasman, W. T. Prognostic significance of hormone receptors in endometrial cancer, Cancer 71, 1467-1470 (1993).
13. Kauppila, A., Kujansuu, E., and Vihko, R. Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin - Clinical correlates: Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium, Cancer 50, 2157-2162 (1982).
14. Creasman, W. T., Soper, J. T., McCarty, K. S., Jr., McCarty, K. S., Sr., Hinshaw, W., and Clarke-Pearson, D. L. Influence of cytoplasmic steroid receptor on prognosis of early stage endometrial carcinoma, Am. J. Obstet. Gynecol. 151, 922-932 (1985).
15. Ehrlich, C. E., Young, P. C., Stehman, F. B., Sutton, G. P., and Alford, W. M. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium, Am. J. Obstet. Gynecol. 158, 796-807 (1988).
16. Chambers, J. T., Macluskey, N., Eisenfeld, A., Kohorn, E. I., Lawrence, R., and Schwartz, P. E. Estrogen and progestin receptors as prognosticators for survival in endometrial cancer, Gynecol. Oncol. 31, 65-81 (1988).
17. Palmer, D. C., Muir, I. M., Alexander, A. I., Cauchi, M., Bennet, R. C., and Quinn, M. A. The prognostic importance of steroid receptors in endometrial carcinoma, Obstet. Gynecol. 72, 388-393 (1988).
18. Kleine, W., Maier, T., Geyer, H., and Pfleiderer, A. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance, Gynecol. Oncol. 38, 59-65 (1990).
19. Charpin, C., Martin, P-M., Lavaut, M. N., Pourreau-Schneider, N., and Toga, M. Estrogen receptor immunocytochemical assay (ER-ICA) in human endometrium, Int. J. Gynecol. Pathol. 5, 119-131 (1986).
20. Press, M. F., Nousek-Goebl, N. A., Bur, M., and Greene, G. L. Estrogen receptor localization in the female genital tract, Am. J. Pathol. 123, 280-292 (1986).
21. Thornton, J. G., and Wells, M. Oestrogen receptor in glands and stroma of normal and neoplastic endometrium: A combined biochemical, immunohistochemical and morphometric study, J. Clin. Pathol. 40, 1437-1444 (1987).
22. Press, M. F., Nousek-Goeble, N., King, W. J., Herbst, A. L., and Greene, G. L. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle, Lab. Invest. 51, 495-503 (1984).
23. Chambers, J. T., Carcangiu, M. L., Voynick, I. M., and Schwartz, P. E. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. II. Correlation between biochemical and immunohistochemical methods and survival, Am. J. Clin. Pathol. 94, 255-260 (1990).
24. Snijders, M. P., De Goeij, A. F., Volovics, A. Prognostic relevance of oestrogen and progesterone receptor immunocytochemistry in endometrial carcinoma, in Oestrogen and progesterone receptors in the human uterus (M. P. Snijders, Ed.), CIP-Gegevens Koninkluke Bibliotheek, The Hague, Netherlands, pp. 93-104 (1990).
25. Mutch, D. G., Soper, J. T., Budwit-Novotny, D. A., Cox, E. B., Creasman, W. T., Flowers, J. L., and McCarty, K. S., Jr. Endometrial adenocarcinoma estrogen receptor content: Association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods, Am. J. Obstet. Gynecol. 157, 924-931 (1987).
26. Carcangiu, M. L., Chambers, J. T., Voynick, I. M., Pirro, M., and Schwartz, P. E. Immunohistological evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma, I, Am. J. Clin. Pathol. 94, 247-254 (1990).
27. Snijders, M., de Goeij, A. F., Thunnissen, E. B., de Haan, J., and Bosnian, R. T. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium, J. Pathol. 166, 171-177 (1992).
28. al Saati, T., Clamens, S., Cohen-Knafo, E., Faye, J. C., Prats, H., Coindre, J. M., Wafflart, J., Caveriviere, P., Bayard, F., and Delsol, G. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER), Int. J. Cancer 55, 651-654 (1993).
29. Pertschuk, L. P., Feldman, J. G., Kim, Y-D., Braithwaite, L., Schneider, F., Braverman, A. E., and Axiotis, C. Estrogen receptor (ER) immunocytochemistry in paraffin with ER 1D5 predicts breast cancer endocrine response more accurately than H222Sp in frozen section or cytosol-based ligand binding assays, Cancer 77, 2514-2519 (1996).
30. Zeimet, A. G., Muller-Holzner, E., Marth, C., and Daxenbichler, G. Immunocytochemical versus biochemical receptor determination in normal and tumerous tissues of the female reproductive tract and the breast, J. Steroid Biochem. Mol. Biol. 49, 365-372 (1994).
31. Snijders, M. P., de Goeij, A. F., Koudstall, J., Scheres, H. M., Stoot, J. E., and Bosman, A. T. Is immunohistochemical analysis of oestrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay? J. Pathol. 161, 129-135 (1990).